MedTech company (name withheld)
£218,000 ERIS claim delivered alongside Innovate UK grant funding
The challenge
An R&D intensive medical device company was part way through an Innovate UK funded programme and had been told by a generalist adviser that grant funded work could not also appear in an R&D tax claim. The company was loss making and heavily dependent on getting both sources of non-dilutive funding right without breaching the rules on subsidised expenditure.
What we did
- Mapped every project cost against the grant award letter to separate grant funded activity from the company's own R&D expenditure.
- Structured the claim under ERIS as an R&D intensive loss making company, applying the subsidised expenditure rules correctly so nothing was double counted.
- Documented the clinical and engineering uncertainties with the technical team and filed the Claim Notification Form and Additional Information Form on time.
The result
£218,000 recovered through ERIS alongside the Innovate UK grant, with the two funding streams reconciled cleanly and no subsidy control conflict.
Written and submitted by the GrantUp team; references available on request.
Let's talk about your project
Talk to us about your grant funding plans and we'll help you make it happen through effective, results-driven grant writing.